Rani Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $1,461 | $0 | $0 | $172 |
Gross Profit | 1,275 | -223 | -240 | 172 |
EBITDA | -8,793 | -6,966 | -10,107 | -11,544 |
EBIT | -8,979 | -7,189 | -10,347 | -11,795 |
Net Income | -10,306 | -5,412 | -6,692 | -7,264 |
Net Change In Cash | 1,461 | 0 | 0 | 172 |
Free Cash Flow | 294 | -5,063 | -5,833 | -8,199 |
Cash | 18,618 | 4,144 | 10,216 | 10,111 |
Basic Shares | 147,093 | 36,542 | 36,542 | 33,440 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,633 | $1,028 | $0 | $0 |
Gross Profit | 733 | 1,028 | -822 | -1,312 |
EBITDA | -37,410 | -50,523 | -65,277 | -61,655 |
EBIT | -38,310 | -51,551 | -66,099 | -62,203 |
Net Income | -29,673 | -30,018 | -33,970 | -30,588 |
Net Change In Cash | 1,633 | 1,028 | 0 | 0 |
Cost of Revenue | -89,946 | |||
Free Cash Flow | -18,802 | -35,764 | -52,465 | -48,134 |
Cash | 18,618 | 3,762 | 5,864 | 27,007 |
Basic Shares | 66,138 | 28,476 | 25,505 | 23,817 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.07 |
2025-09-30 | -$0.12 |
2025-06-30 | -$0.18 |
